Lesson plan

AOH1996

AOH1996 is an experimental anticancer medication which acts as a small molecule inhibitor of proliferating cell nuclear antigen (PCNA) and is in Phase I clinical trials at City of Hope as of August 2023 for the treatment of solid tumors. AOH1996 was created to target a post-translationally modified isoform of PCNA, termed caPCNA, which is preferentially found in cancer cells. PCNA is crucial in the body for DNA repair, but targeting it is difficult because of its role in healthy cells. By selectively targeting caPCNA, it may be possible to kill cancer cells without affecting healthy tissues. In vitro testing demonstrated that AOH1996 inhibited the growth and induced cell cycle arrest and apoptotic cell death in a wide variety of cancer cell lines, but had no effect on several normal, nonmalignant cell types. In mouse and dog animal models, there were no observed side effects or toxicity even at six times the effective dose. It could be used either as a monotherapy (single drug regimen) or in combination with one or more other chemotherapy drugs. Although the press described it as a "miracle drug" that would cure cancer, some experts have expressed skepticism.…

Back to article

Article summary

AOH1996 is an experimental anticancer medication which acts as a small molecule inhibitor of proliferating cell nuclear antigen (PCNA) and is in Phase I clinical trials at City of Hope as of August 2023 for the treatment of solid tumors. AOH1996 was created to target a post-translationally modified isoform of PCNA, termed caPCNA, which is preferentially found in cancer cells. PCNA is crucial in the body for DNA repair, but targeting it is difficult because of its role in healthy cells. By selectively targeting caPCNA, it may be possible to kill cancer cells without affecting healthy tissues. In vitro testing demonstrated that AOH1996 inhibited the growth and induced cell cycle arrest and apoptotic cell death in a wide variety of cancer cell lines, but had no effect on several normal, nonmalignant cell types. In mouse and dog animal models, there were no observed side effects or toxicity even at six times the effective dose. It could be used either as a monotherapy (single drug regimen) or in combination with one or more other chemotherapy drugs. Although the press described it as a "miracle drug" that would cure cancer, some experts have expressed skepticism.…

Key claims

  1. date of death: 2006 — source: Wikipedia, revision 1330121940, retrieved 2026-10-20 · confidence 0.95

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. The record states that the date of death is "2006". What evidence would count against this claim?
  3. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  4. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

  1. Wikipedia, “AOH1996”, revision 1330121940, retrieved 2026-10-20 https://en.wikipedia.org/w/index.php?oldid=1330121940

Key claims and bibliography are generated from the same tracked claims and sources as the article page.